CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Innovassynth Technologies (India) Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Innovassynth Technologies (India) Ltd
Flat No. C-2/3
KMC-91,, Innovassynth Colony
Phone: +91 2192260100p:+91 2192260100 KHOPOLI, 410203  India Ticker: 533315533315
Business Summary
Innovassynth Technologies (India) Limited, formerly Innovassynth Investments Limited, is an India-based company, which is engaged in developing, scaling up and manufacturing of specialty chemicals and pharmaceuticals intermediates. The Company is engaged in custom development and manufacturing. It partners with pharma and diagnostics, organometallics, petrochemical and polymers, flavors and fragrance, and specialty chemical companies worldwide. Through its two business verticals, the Company offers solutions and a range organic chemical portfolio: life sciences - nucleosides and specialty chemicals. Its Life Sciences - Nucleosides vertical includes Nucleosides - Phosphoramidite, Delivery Platforms (GalNAc), Pharma Intermediates, Nucleosides - Reagents & Bio-buffers, and ADC Linkers. Its specialty chemicals include organometallics including pre-catalysts for metallocene, ZN catalysts and donors, polymers additives, ALD/CVD precursors, donors & ligands, and semiconductor chemicals.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20253/31/2025Yes----

Industries
SIC Code Description
2869 Industrial organic chemicals, not elsewhere classified
2819 Industrial inorganic chemicals, not elsewhere classified
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board ProsenjitGupta 12/23/2025 8/14/2025
Chief Executive Officer, Managing Director HardikJoshipura 12/23/2025 2/12/2022
Chief Financial Officer JayeshPatel 51 12/23/2025 12/23/2025
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2 (As of 3/31/2025)
Outstanding Shares: 75,449,316 (As of 12/23/2025)
Stock Exchange: BOM
Fax Number: +91 2228511809


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026